RESEARCH PROFILE
EPITHALON
Synthetic Tetrapeptide • Telomere & Aging Biology Research
Epithalon, also spelled Epitalon, is a synthetic four-amino-acid peptide developed from research involving pineal peptide extracts. Research has focused on telomerase activity, telomere biology, circadian rhythm, melatonin signaling, and aging-related cellular processes.
The evidence base includes cell and animal studies, limited human reports, and older human peptide-extract research, but no large blinded human trial establishing lifespan extension or clinically meaningful anti-aging effects from synthetic Epithalon.
INVESTIGATIONAL • NOT FDA APPROVED • LIMITED HUMAN EVIDENCE
EPITHALON AT A GLANCE
Category
Longevity and cellular-aging research peptide
Other Names
Epitalon • AEDG
Structure
Tetrapeptide
Sequence
Ala-Glu-Asp-Gly
Primary Research Focus
Telomerase • Telomeres • Circadian rhythm • Melatonin • Aging biology
Evidence Base
Cell, animal, older extract-based human research, limited synthetic-peptide human data
Regulatory Status
Not FDA approved
IMPORTANT DISTINCTION
Epithalon and epithalamin are related historically but are not the same material.
Epithalon is a synthetic four-amino-acid peptide.
Epithalamin refers to a broader pineal peptide extract used in some older human studies.
Your Project profile specifically cautions that favorable longevity or mortality findings from epithalamin research should not automatically be attributed to synthetic Epithalon.
WHAT IS EPITHALON?
Epithalon is a synthetic tetrapeptide composed of:
Alanine • Glutamic acid • Aspartic acid • Glycine
It is commonly abbreviated as AEDG.
The peptide was developed from research into short regulatory peptides associated with the pineal gland.
The pineal gland plays an important role in:
Melatonin production
Circadian rhythm
Sleep-wake timing
Neuroendocrine signaling
Epithalon research has therefore focused on two major areas:
Cellular aging and telomere biology
Circadian and pineal signaling
The peptide is often discussed in longevity circles because of studies examining telomerase activity and telomere length.
However, the Project source is clear that the strongest anti-aging claims go beyond what has been established in modern, controlled human trials.
MECHANISM OF ACTION
Epithalon does not have one fully established human mechanism of action.
Its proposed biology comes primarily from cell, animal, and older peptide research.
TELOMERASE ACTIVITY
One of the most discussed mechanisms involves telomerase, the enzyme that can add DNA repeats back to chromosome ends.
Human somatic cells typically show limited telomerase activity.
Laboratory studies cited in your Project profile reported increased telomerase activity in human fibroblast cultures exposed to synthetic Epithalon.
TELOMERE BIOLOGY
Telomeres are protective DNA-protein structures located at chromosome ends.
They generally shorten with repeated cell division.
In vitro studies reported changes in telomere length following exposure to Epithalon.
This is one reason the peptide became associated with longevity research.
CELLULAR REPLICATIVE CAPACITY
The Project source cites cell studies reporting that Epithalon-treated fibroblasts continued dividing beyond expected replicative limits.
This has been interpreted as a possible effect on cellular aging.
However, cell-culture lifespan is not the same as human lifespan.
PINEAL & MELATONIN SIGNALING
Epithalon is also associated with research involving the pineal gland and circadian biology.
Older extract-based and peptide research reported changes in:
Melatonin rhythm
Circadian timing
Neuroendocrine regulation
GENE & REGULATORY SIGNALING
Short peptide research has also explored whether Epithalon-like peptides influence gene regulation and cellular differentiation.
These areas remain mechanistic and incompletely characterized.
IMPORTANT MECHANISM LIMITATION
Telomerase activation in a cell culture does not establish that injecting synthetic Epithalon lengthens telomeres throughout the human body or extends human lifespan.
That distinction should remain explicit.
WHAT THE RESEARCH SHOWS
HUMAN CELL RESEARCH
One of the better-known studies involved human fibroblast cultures.
Your Project source cites research reporting that Epithalon increased telomerase activity and was associated with telomere elongation and extended cellular replicative capacity.
This is in-vitro evidence.
INDEPENDENT CELL RESEARCH
Your Project source also cites more recent independent work examining telomere length in human cell lines.
That research reported telomere lengthening in some cell systems, though the degree and reproducibility differed from the earlier Russian literature.
This provides useful mechanistic support but remains cell-based evidence.
HUMAN PINEAL-EXTRACT RESEARCH
Older Russian studies using epithalamin, not necessarily synthetic Epithalon, reported outcomes involving:
Mortality
Cardiovascular events
Circadian rhythm
Melatonin patterns
Some long-term observational studies reported lower mortality in treated groups.
However, these studies were not modern large-scale blinded randomized trials, and the intervention was often a pineal extract, not pure synthetic Epithalon.
CIRCADIAN & MELATONIN RESEARCH
Older human research reported changes in melatonin rhythm and circadian signaling in elderly participants.
These findings are relevant to pineal biology but should be attributed to the specific preparation studied.
ANIMAL LONGEVITY RESEARCH
Animal studies cited in the Project profile reported:
Longer lifespan in some rodent models
Changes in spontaneous tumor incidence
Effects on aging biomarkers
Neuroendocrine changes
These findings helped create the longevity narrative around Epithalon.
They remain preclinical.
SINGLE HUMAN CASE REPORT
Your Project profile also cites a 2023 case report involving self-administered Epithalon with reported changes in telomere or biological-age markers.
A single case cannot establish efficacy.
THE HONEST SUMMARY
The strongest evidence can be summarized as:
Human cells: telomerase and telomere-related activity observed
Animals: aging and lifespan-related signals reported in some models
Older human extract research: interesting mortality and circadian findings
Synthetic Epithalon in modern human trials: very limited
IMPORTANT EVIDENCE LIMITATION
There is no large, blinded, placebo-controlled human trial proving that synthetic injected Epithalon:
Extends human lifespan
Reverses biological aging
Lengthens telomeres throughout the body
Prevents cancer
Prevents cardiovascular disease
Improves sleep in a clinically established way
Claims beyond the available evidence should remain clearly labeled as investigational.
SAFETY & RESEARCH CONSIDERATIONS
Human safety data for synthetic Epithalon are limited.
Most reported safety observations come from older peptide literature, small studies, case reports, and community use rather than modern large clinical trials.
REPORTED EFFECTS
Your Project profile identifies commonly reported effects such as:
Injection-site redness
Injection-site soreness
Small local bumps
Mild drowsiness
Occasional headache
Temporary sleep-cycle changes
MELATONIN & CIRCADIAN EFFECTS
Because Epithalon is often associated with pineal and melatonin signaling, some individuals may report changes in sleep timing or drowsiness.
These observations are not a substitute for controlled sleep research.
CANCER & TELOMERASE CONCERN
This is one of the most important theoretical safety questions.
Telomerase can support continued cell division.
Because many cancers also activate telomerase, your Project profile identifies active cancer or recent cancer history as an important area of caution.
At the same time, some animal studies reported reduced spontaneous tumor incidence.
These findings are not sufficient to conclude that Epithalon is either anti-cancer or cancer-promoting in humans.
LONG-TERM UNCERTAINTY
The largest safety gap is the absence of robust long-term human data.
There is no well-characterized modern safety database for repeated injectable synthetic Epithalon use.
PREGNANCY & BREASTFEEDING
Your Project source identifies insufficient safety data for use during pregnancy or lactation.
PRODUCT QUALITY
Research-grade peptide quality adds an independent layer of risk.
Potential concerns include:
Incorrect identity
Incorrect concentration
Degradation
Contamination
Sterility failure
Lot-to-lot variability
Lot-specific analytical testing can characterize a sample but cannot establish clinical safety.
REGULATORY CONTEXT
EPITHALON IS NOT FDA APPROVED
Epithalon is not an FDA-approved drug for any medical indication.
There is no FDA-approved prescription Epithalon product in the United States.
RESEARCH-USE STATUS
Your Project source identifies Epithalon as sold in research-use contexts.
A research-use label does not establish safety, effectiveness, legality for human use, or medical suitability.
NOT AN APPROVED DIETARY SUPPLEMENT
The Project profile also notes that Epithalon is not established as an approved dietary supplement or conventional medicine in the United States.
INTERNATIONAL HISTORY
Much of the longevity-related human literature originates from Russia and Ukraine and involves research traditions and regulatory environments different from current U.S. pharmaceutical standards.
IMPORTANT REGULATORY DISTINCTION
Historical clinical use abroad ≠ FDA approval
Research-use sale ≠ approved medical use
Published longevity claims ≠ regulatory validation
CURRENT STATUS
As reflected in the Project profile:
Epithalon remains investigational and is not FDA approved.
ANALYTICAL DOCUMENTATION
Croix maintains available third party analytical documentation only for specific samples and lots that can be matched to corresponding laboratory reports.
EPITHALON 10 MG
Laboratory
Optiq Health Labs
Sample Name
Epitalon 10mg
Lot
ld07102026-3
Sample ID
1265.OPT.260910
Sample Matrix
Lyophilized Peptide
Intended Use
Research Use Only
Report Date
September 18, 2026
Reported Net Content
10.14 mg/vial
Reported Purity
99.2%
Identity
LC-MS Confirmation • Epitalon Tested
Endotoxin
Pass • LAL ≤ 0.05 EU/mg
Sterility
Pass • USP <71> • No Growth COAs-2(2)
IMPORTANT COA LIMITATION
Analytical results apply only to the specific sample identified in the corresponding laboratory report.
A Certificate of Analysis for one sample does not establish the composition, purity, sterility, safety, efficacy, or characteristics of another sample, lot, batch, or product.
Croix requires the product, strength, lot or batch, sample ID, laboratory, and report date to be matched before analytical documentation is represented as supporting a product.
A passing COA does not establish FDA approval, clinical efficacy, medical suitability, or the characteristics of unrelated lots.
SELECTED RESEARCH & REFERENCES
Khavinson VK, Bondarev IE, Butyugov AA.
Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells.
Bulletin of Experimental Biology and Medicine. 2003.
Foundational in-vitro telomerase and telomere research.
Korkushko OV, Khavinson VK, Shatilo VB, Antonyuk-Shcheglova IA.
Research examining geroprotective effects of epithalamin in elderly subjects.
Older human peptide-extract research.
Khavinson VK, et al.
Effects of long-term peptide bioregulator administration on mortality in elderly subjects.
Neuroendocrinology Letters. 2003.
Long-term human peptide-extract research.
Korkushko OV, Khavinson VK, Shatilo VB, Magdich LV.
Research examining epithalamin and circadian rhythm of pineal melatonin function.
Human circadian and melatonin research.
Anisimov VN, Khavinson VK, et al.
Animal research examining Epithalon, lifespan, aging biomarkers, and spontaneous tumor incidence.
Khavinson V, Goncharova N, Lapin B.
Research examining synthetic tetrapeptide Epithalon and neuroendocrine regulation.
Al-Dulaimi T, et al.
Epitalon increases telomere length in human cell lines through telomerase upregulation or ALT activity.
Biogerontology. 2025.
Independent cell-based telomere research.
Cognitive Vitality / Alzheimer's Drug Discovery Foundation
Research assessment of epithalamin and Epithalon evidence and safety.
U.S. Food & Drug Administration
Regulatory context confirming that Epithalon is not an FDA-approved drug.
EVIDENCE NOTE
Epithalon has an unusual evidence history.
Its strongest mechanistic evidence involves human cell studies, while much of the favorable long-term human longevity literature involves epithalamin or older peptide preparations rather than modern synthetic Epithalon.
These sources should not be combined into a claim that injectable synthetic Epithalon has been proven to extend human lifespan.
RESEARCH & EDUCATIONAL INFORMATION
This profile is provided for research and educational reference. It does not constitute individualized medical advice or establish Epithalon as safe or effective for personal use.
Epithalon is an investigational synthetic tetrapeptide studied in relation to telomerase, telomere biology, circadian signaling, melatonin, and aging-related cellular processes.
Epithalon is not FDA approved for any therapeutic indication.
Cell-culture findings involving telomerase and telomeres, animal longevity findings, and older human pineal-extract research should not be interpreted as proof that synthetic injectable Epithalon extends human lifespan, reverses aging, or prevents disease.
Analytical documentation presented by Croix applies only to the specific samples and lots identified in corresponding laboratory reports.